211 top medical experts on Sandhoff Disease across 21 countries and 14 U.S. states, including 44 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Sandhoff Disease: An autosomal recessive neurodegenerative disorder characterized by an accumulation of G(M2) ganglioside in neurons and other tissues. It is caused by mutation in the common beta subunit of hexosaminidase A and hexosaminidase B. Thus this disease is also known as the O variant since both hexosaminidase A and B are missing. Clinically, it is indistinguishable from TAY-sachs disease.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): GM2 Gangliosidoses (357).
  4. Clinical Trials ClinicalTrials.gov : at least 16 including 3 Active, 6 Completed, 5 Recruiting
  5. Synonyms: Type II G(M2) Gangliosidosis,  Type II Gangliosidosis G(M2),  Hexosaminidase A and B Deficiency Disease


  

        

                    


    Computing Expert Listing ...

);